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Abstract 
Background: Thalassemia major is a chronic 
disease that presents as a range of serious clinical 
and psychological challenges. The effect of thalassemia 
on physical health can lead to deformity, growth 
retardation and delayed puberty. We conducted this 
study to assess quality of life of thalassemia major 
patients registered in thalassemia treatment centers of 
Rawalpindi. 
Methods: This descriptive  cross-sectional  study was 
done in TTC (Thalassemia Treatment Center) of HFH 
(Holy family hospital) and Thalassemia House in 
Rawalpindi from January 2018 to March 2018 after 
ethical approval from Institutional  Research  Forum of 
Rawalpindi Medical University. A total of 120 
thalassemic patients ranging from 5 to  28  years  of age 
brought for blood transfusion were included. Patients 
having impaired cognitive functions and those having 
multiple comorbidities  were excluded. A modified 
version of WHO QOL BREF questionnaire was 
developed to assess the physical, psychological, 
environmental and social aspects of Quality of Life. 
Data was entered on SPSS v 22 and descriptive 
statistics were applied. 
Results: Out of 120 patients surveyed,  majority  were 
females (55.83 %) with a mean age of 10.22± 4.5 years. 
Forty four percent of the patients were males with 
mean age of 11.42± 5.19 years. Quality of life of these 
patients was found to be 68.8%. In females it was 69.34 
% and in males it was 68.15%. Quality of  life was 
significantly associated with psychological (p<0.05), 
social (p=0.009) and  physical  (p<0.05) factors. Poorer 
quality of life was found against environmental 
(financial resources, transport, healthcare) aspects 
(63.13%). Adverse impact of thalassemia was also 
found on physical (67.88%) and psychological (68.82%) 
quality of life of patients. Social Quality of life was 
found to be (92.3%). 
Conclusion: Poor psychological  support  along with  
other environmental and physical aspects lead  to lower 
Quality of life of β thalassemia major 
Introduction 
Hemoglobinopathies are genetic blood disorders that 
globally affect more than 300,000 newborns each year. 
(1) Thalassemia, which is found in more than 60 countries, 
has been recognized as the most prevalent blood 
disorder globally by  World  Health Organization. (2) 
Thalassemia occurs because of mutations in hemoglobin 
gene clusters that result in impaired synthesis of one or 
more chains  of hemoglobin tetramer. (3) Depending upon 
the type of Hemoglobin chain involved, there are two 
distinct forms of thalassemia; alpha and beta 
thalassemia. (4) Beta thalassemia is the most important 
type as it is widely prevalent and results in severe 
anemia in homozygous and compound heterozygous  
state.  (5) Beta thalassemia exhibits diverse clinical 
manifestations. In mild cases, there is no treatment 
needed; on the contrary in severe cases there is severe 
anemia with significant deteriorations in the  bones  that 
can be fatal without appropriate intervention in 
childhood. (6) 
Thalassemia has a high prevalence in Mediterranean, 
Middle East, Indian sub-continent, South East-Asia, 
Melanesia and Pacific Islands. (7) World Health 
Organization statistics show that frequencies of 
thalassemia in these areas range from 0.1 to 4.9/1000 live 
births. However, in the recent years due to migrations 
hemoglobinopathies are no  longer  restricted to these 
high incidence areas. (8) Studies state that 3 to 10% of the 
world population carries thalassemia gene (9). There are 
about 200,000 documented patients of thalassemia  with 
an increase  of about 60,000 each year (10). In Pakistan, 
Thalassemia  is seen in almost all parts of the country (11). 
Every year 5000 babies are born with thalassemia; five 
out of 100 people are currently suffering with around 8 
million people being carriers of thalassemia. (11,12). 
Clinically thalassemia is divided into Transfusion 
dependent and 
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nondependent. The only  curative  treatment of 
Transfusion dependent Thalassemia Major is allogenic 
marrow transplantation from an HLA-identical 
relative. This treatment inflicts  significant  one-time 
cost and is still limited by the availability of donor and 
high risk of graft vs host disease. (13,14) Current 
management of Transfusion dependent thalassemia is 
done by regular blood transfusions to maintain Hb 
level>9mg/dl. Regular blood transfusions lead to iron 
overload and thus organ damage in these patients. (15) 
For chronic diseases like thalassemia, quality of  life  
and not just survival is an important aspect for 
provision of proper healthcare. The assessment of 
HRQOL (Health related Quality of life) is an important 
tool of patient care. Quality of life is defined as impact 
of disease and the treatment methods on Physical, 
Psychological, Social and environmental aspects of a 
person’s life. An important reason to determine  QOL  
is to determine the range of problems that affect the 
patient (16). 
Quality of life of patients with thalassemia has been 
reported in Europe and the United  States;  however, the 
results show variations due to cultural and 
socioeconomic differences in the targeted populations 
(17). Quality of Life of individuals with thalassemia is 
influenced by a number of factors such as burden of 
having a chronic disease, physical appearance, treatment 
modalities including multiple visits to the hospitals for 
transfusions, complications of the disease, uncertainty 
regarding the future and expectation of early death (18,19). 
There has been improvement in HRQOL in thalassemic 
patients in developed countries but there are very few 
published studies on QOL of thalassemic patients in 
developing countries such as Pakistan where the 
prevalence is quite high.  This  study was therefore 
designed to assess the Quality of Life of thalassemic 
patients in physical, psychological, social and 
environmental domains of their lives. 
 
Materials and Methods: 
It was a cross sectional study conducted in the 
Thalassemia Treatment Center of Holy  Family  Hospital  
of  Rawalpindi  from  January   2018   to March 2018 after 
taking ethical approval from Institutional  Research   
Forum   of   Rawalpindi Medical University. Non-
probability Convenient sampling  was  done  and   120   
patients   were included  in  this  study.  Patients  ranging  
in  age   from 5  to  28  years  diagnosed  with  thalassemia  
major  who  were  on  regular  blood  transfusions   were 
included. Patients  with  impaired  cognitive  skills; those 
with multiple comorbidities and 
those unwilling to participate were excluded. A 
modified  version  of  WHO   QOL   BREF  questionnaire 
was used. The questionnaire was translated  into  Urdu  
prior   to   the   data   collection. A pilot  study  was  
conducted  on  10  patients; statistics were applied on that 
data and then questionnaire  was   administered   to   the   
participants.  The  questionnaire  included  20  questions 
that were  developed  to  evaluate  the Quality of  Life  in  
4  domains  (physical,  psychological,    environmental     
and     social). Physical  Quality  of  Life   was   assessed   
by   questions related to pain, sleep and tiredness. 
Psychological QOL was assessed using questions related   
to   depression,    negative    feelings, confidence in 
treatment,  satisfaction  and concentration.  Social  QOL  
included   relationship  with  family   members   and   
loneliness. Environmental QOL included
 financial difficulties,  healthcare  
and   transport   difficulties.  The  patients’  responses  to  
these  questions   are shown (table II). Likert scale 5 was 
used to score individual questions.  Scores  were  scaled  
in  a  positive direction i.e. higher score denotes higher 
quality  of  life.  The  mean   score   of   questions   within 
each domain was  used  to  calculate  the  domain  score.  
Domain  scores  were   then   summed to get the overall 
Quality of Life score. Data were entered   on   SPSS   v22.    
Frequencies    were calculated  for  age,  gender,  
residence  and  educational status. (Table III) Percentages 
were calculated  for  Quality  of  life  scores.  (Table   I)   
T- test  and  one-way  ANOVA  test  were  applied  to   
find statistical significance. P-value <0.05 was 
considered statistically significant. 
 
Results 
A total of 120 patients were included in this study; sixty-
seven were females with a mean age of 10.22 ± 
4.5  years  whereas  53  were  males with a  mean age  of 
11.42 ± 5.19 years. Forty eight percent of the patients 
lived in rural areas. All of the patients  were  transfusion 
dependent. Twelve percent were receiving once weekly 
transfusions, 45% twice a month, 8%  thrice a month and 
36% were receiving once monthly transfusions. Blood 
groups of the participants were as: A+ve (19%), B+ve 
(37.5%), AB+ve (14.2%), O+ve (21.7%), A-ve (8%), B-ve 
(3.3%), AB-ve (0.8%), O-ve (2.5%). Quality of life was 
calculated to be  68.8%.  It was 69.34% in females and 
68.15% in males. Quality of life in its four domains was 
calculated as;  Physical  QOL  (67.88%),  psychological  
(68.82%),  social  (92.3%) 
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and environmental (63.13%), (Table  I).  Patients living in 
urban areas had a mean quality of life score of 71% and 
those living in rural areas had mean score of 66%. 
 
QOL SCORE 
Physical 67.88% 
Psychological 68.82% 
Environmental 63.13% 
Social 92.3% 
Overall 68.80% 
Table I: Quality of life  in  Thalassemia  Major Patients 
 
While assessing physical QOL, it was observed that 
75.8% of the patients endured pain and 35.8% of the total 
suffered from extreme amount of pain during  their 
course of treatment. Significant association was found 
for pain (p=0.013) with overall quality of life. Sleep 
difficulties were found in about 30.8% of the 
patients, 43% of these suffered  from extreme  amount of 
sleep difficulties. Majority of patients told that they get 
too tired at times and are unable to carry  out routine 
chores. Seventeen percent of patients suffered from 
extreme tiredness during the course of their treatment. 
Similarly, psychological QOL showed depression, 
anxiety and lack of confidence in the patients. About 
17.5% of the patients  had  no confidence in success of 
their treatment and another 24.16% had very little 
confidence. Social QOL was found to be better than other 
domains. Considering financial difficulties, 72 out of 120 
suffered from financial difficulties and 27.7% of these 
suffered from severe financial crisis during the 
transfusions. Disease affected the education of patients; 
30% of the total  could never study, 57 .5% studied up to 
primary  school, 8.3% in secondary school and only  4.2%  
studied beyond secondary school. Eighteen percent of 
the patients were not confident about the  success  of the 
treatment they were receiving. Sixty one percent of 
 
QOL Index Type Not At 
All 
A 
Little 
Moderate Very Much An Extreme 
Amount 
Physical      
How often do you suffer from pain? 29 34 14 31 12 
Do you worry about your pain? 49 14 24 35 8 
How difficult is it for you to handle pain or 
discomfort? 
45 25 16 22 12 
How easily do you get tired? 10 7 11 72 20 
Do you have any difficulties with sleeping? 83 9 12 11 5 
Psychological      
How much confidence do you have in success 
of your treatment? 
21 29 19 49 2 
How worried do you feel about your disease? 46 21 11 34 8 
How much do the feelings of depression or 
sadness interfere with your everyday 
functioning? 
61 12 15 29 3 
How often do you have negative feelings such 
as anxiety? 
48 21 17 32 2 
How satisfied are you with your health? 4 28 38 45 5 
How satisfied are you with your life? 3 21 45 46 5 
Social      
Do you feel happy about your relationship 
with your family members? 
0 9 7 38 71 
How alone do you feel in your life? 106 6 3 4 1 
Environmental      
Do you have financial difficulties? 48 10 18 24 20 
How easily are you able to get good medical 
care? 
44 20 11 16 29 
How much do 
restrict your life? 
difficulties with transport 49 17 11 20 23 
Table II: Responses of the participants of the study 
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the patients were worried about their disease and had 
low confidence in success of their treatment. Sixty 
percent of the patients had negative feelings and  49.16% 
had marked feelings of depression  and  sadness. 
Significant association was found for pain (p=0.01), 
distress due to pain (p<0.01), tiredness (p=0.009), 
sleeping difficulties (p=0.07), worry due to disease 
(p=0.01), depression or sadness (p<0.05), anxiety and 
negative thoughts (p<0.01), satisfaction with health 
(p=<0.01), satisfaction with life (p=0.08). 
 
Parameter Frequency Qol 
Score(%) 
P-Value 
Age 10.75 4.86  <0.001 
Gender   <0.001 
Male 53 68.15  
Female 67 69.34  
Education   0.151 
Not Studying 36 68.08  
Primary School 69 67.75  
Secondary School 10 75.6  
Higher 5 75.2  
Address   <0.001 
Urban 63 71.28  
Rural 57 66.08  
Transfusion 
Time 
  0.005 
Monthly 43 73.16  
Once In 3 Weeks 9 71  
Once In 2 Weeks 54 65.09  
Weekly 14 67.8  
Table III: Demographic Charactersitics  of  the Patients
 and Significant Relations. 
 
Quality  of  life  of  patients  was   found   to   be  affected   
by   number   of   blood    transfusions  patients  per   
month.   Those   receiving   monthly blood transfusions 
had better Quality of scores as compared  to  those  
receiving  biweekly.  Quality  of life   scores   of   patients   
receiving   blood   transfusions once, twice, thrice and  
four  times  a month  were  found  to   be   73.16%,   71%,   
65.09%  and 67.8% respectively. Quality of  life  score  was 
found  to  be  significantly   associated   with  transfusion 
interval of patients (p=0.005). 
 
Discussion 
Quality of life is an indicator of overall wellbeing of an 
individual and has become an important tool to assess 
the impact of a chronic disease on various aspects of 
patients’ life. There have been a limited number of 
studies on health-related quality of life of thalassemia 
patients. Thalassemia major is a condition that 
deleteriously affects the life activities of patients (22). This 
study found that patients suffering from thalassemia 
suffer from psychological stress and a number of 
physical impairments such as enduring severe amount 
of pain, tiredness and sleep difficulties. Thalassemia 
being a chronic disease restricts life activities, capabilities 
and relationships of patients leading to negative impact 
on physical, psychological and social quality of life. 
Regular blood transfusions are required to maintain 
normal hemoglobin levels in patients with thalassemia 
major. Patients’ quality of life is strongly influenced by 
the number of transfusions they receive in  a  month; the 
transfusion interval. Greater the transfusion interval, 
better the quality of life scores and vice versa. Shorter 
transfusion interval is associated with complications 
related to iron overload. Such patients are at increased 
risk of organ damage such as heart failure. Multiple 
transfusions put a lot of financial burden on patients. 
Multiple hospital visits, non- availability of blood and 
transport difficulties add to  the distress of patients. 
Those receiving once monthly transfusions had better 
quality of life scores as compared to those receiving 
multiple transfusion per month. 
In a study conducted in Egypt using Pediatric Quality of 
Life Inventory 4.0 Generic Core Scale, the mean quality 
of life score was 63.74(SD 13.2).  Physical domain score 
was 58.46(SD 18).(24) Similarly, in another study 
conducted in Iraq, the lowest scores were encountered in 
physical domain at 61%(SD 13.37).(25) In these studies 
physical domain scores are as compared  to this study. 
This is due to the fact that the mean age  of patients 
included was higher as compared to this study. With 
increase in age there is increase in complications 
associated with thalassemia major such as organ failure 
and thus lower quality of life scores. 
In contrast to previous studies conducted in Pakistan, 
significant association was found with residential 
address of patients. Patients living in rural areas had low 
quality of life scores. This can be explained by the fact 
that thalassemia treatment centers are very few in 
number and that too are located in big cities. Patients face 
transport difficulties as they travel to cities for blood 
transfusions. On the contrary, those living in urban areas 
have access to transfusion centers and face lesser 
difficulties so their quality of life was found to better. 
In a few studies conducted, it is shown that 
psychological and social aspects of life of thalassemia 
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patients are affected adversely. This  study  showed  that 
patients had negative feelings, anxiety and lack of 
confidence in the success of treatment. Patient suffer 
from psychological trauma that is attributed to the 
chronic nature of disease limiting the life of patients. 
Regarding family relationships, patients felt happy 
about their relationship with their family members.  This 
may be due to the protective and caring attitude   of 
parents towards their sick children. Education was also 
affected that is also attributable to the chronic nature of 
disease; limiting their normal study routine. Barrier to 
proper education is also attributed to the physical 
stresses such as extreme amount of pain and tiredness 
experienced by the patients. In this study, psychological 
QOL assessment showed that patients were uncertain 
about the success of their treatment. 
This study was done to determine the Quality of Life   of 
thalassemia major patients in Pakistan where there have 
been very few previous studies. This  study focuses on 
the view that physical impairments,  stresses, financial 
burden and  problems  with education make thalassemia 
patients vulnerable to psychological and trauma very 
early in their life. 
 
Conclusion 
Quality of  life is significantly reduced in majority of  the 
beta thalassemia patients. Apart from conventional 
therapy, psychological support programs should be 
developed to improve the Quality of Life of  thalassemia 
major patients. 
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